Related Experiment Video
Updated: Aug 23, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
From Prescription Drugs to Natural Health Products: Medication Use in Canadian Infants
Pascal Bedard1, Geoffrey L Winsor2, Emma S Garlock2
1Department of Pharmacy, CHU Sainte-Justine, Montreal, QC H3T 1C5, Canada.
Insights
Nearly all infants use pharmaceutical products by age one, with common use of over-the-counter medications and natural health products (NHPs). Off-label drug use is frequent in infants, underscoring the need for monitoring.
Area of Science:
- Pediatrics
- Pharmacology
- Public Health
Background:
- Limited data exists on pharmaceutical product use in infants.
- Available data suggests higher prevalence of use among children under 12 months of age.
Purpose of the Study:
- To describe the prevalence and patterns of pharmaceutical product use in infants up to one year of age.
- To identify common medications, natural health products (NHPs), and off-label drug use in the first year of life.
Main Methods:
- Descriptive study of 3050 infants from the prospective, multicenter CHILD Cohort Study.
- Parental surveys at 3, 6, and 12 months postpartum for medication and NHP use.
- Analysis of reported products, including prescription drugs, over-the-counter (OTC) medications, and NHPs (vitamins, homeopathic products).
Main Results:
- By one year of age, 96.0% of infants had used at least one pharmaceutical product.
- Commonly used products included Vitamin D, acetaminophen, ibuprofen, topical hydrocortisone, amoxicillin, and nystatin.
- 14.7% of products were used off-label, and 35.8% were NHPs or products without a Drug Identification Number (DIN).
Conclusions:
- Over-the-counter medication and NHP use is common in infants.
- Off-label drug use is frequent, even within the first year of life.
- Highlights the need for infant medication use studies and healthcare provider monitoring.
Abstract:
Limited data exist on pharmaceutical product use by infants, although available data suggests higher prevalence of use among children under 12 months of age. We conducted a descriptive study of 3050 infants recruited in the CHILD Cohort Study, a prospective, multicenter, longitudinal cohort following children from pregnancy through childhood. Parents were surveyed for use of prescription and over-the-counter drugs, and natural health products (NHPs, including homeopathic products and vitamins) at 3, 6, and 12 months after delivery. By one year of age, 96.0% of children had taken at least one pharmaceutical product. Among 307 reported products, 32 were given to at least 1% of cohort infants. Vitamin D, acetaminophen, ibuprofen, topical hydrocortisone, amoxicillin, and nystatin were the most common medications and natural health products (NHPs) received, with 8/32 of the most frequently used products being NHPs. Overall, 14.7% of pharmaceutical products administered to children were off-label and 35.8% were NHPs or products without a Drug Identification Number (DIN). The use of over-the-counter medications and NHPs is common and off-label use of drugs is frequent, even in the first year of life. This study highlights the importance of conducting studies on medication use in infants, and of infant medication use monitoring by healthcare providers.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Factors Affecting Drug Response: Overview
Drug Classes and Categories
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Therapy
Antianxiety Medications